BIBLIOGRAFÍA

MEN 1

  • Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
  • Rajesh V. Thakker et al. J Clin Endocrinol Metab 2012; 97: 2990–3011

    http://jcem.endojournals.org/content/97/9/2990.full.pdf+html

  • Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
  • Maria Luisa Brandi et al J Clin Endocrinol Metab 2001; 86(12):5658–5671

    http://jcem.endojournals.org/content/86/12/5658.full.pdf+html

  • Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1
  • Göran Åkerström, Peter Stålberg, and Per Hellman. Clinics 2012;67(S1):173-178

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328819/pdf/cln-67-s1-173.pdf

  • Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients
  • Masayuki Imamura, Izumi Komoto, Shuichi Ota, Takuya Hiratsuka, Shinji Kosugi, Ryuichiro Doi, Masaaki Awane, Naoya Inoue World J Gastroenterol 2011 March 14; 17(10): 1343-1353

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068271/pdf/WJG-17-1343.pdf

  • Post-surgical follow-up of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1
  • Flavia L. Coutinho, Delmar M. Lourenco, Jr., [...], and Sergio P. A. Toledo. CLINICS 2012;67(S1):169-172

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328812/pdf/cln-67-s1-169.pdf

  • Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d’etude des Tumeurs Endocrines database
  • B Gatta-Cherifi et al. European Journal of Endocrinology (2012)166 269–279

    http://eje-online.org/content/166/2/269.full.pdf+html

  • Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery?
  • Francesca Giusti, Francesco Tonelli, and Maria Luisa Brandi. Clinics 2012; 67: 141-44

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328829/pdf/cln-67-s1-141.pdf

  • Diagnosis of Zollinger-Ellison syndrome: Increasingly difficult
  • Tetsuhide Ito, Guillaume Cadiot, Robert T Jensen. World J Gastroenterol 2012 October 21; 18(39): 5495-5503

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482635/pdf/WJG-18-5495.pdf

  • Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype–phenotype correlation
  • Cornelis J. Lips, Koen M. Dreijerink, Jo W. Hoppener Clinics 2012;67(S1):49-56

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328827/pdf/cln-67-s1-49.pdf

  • Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1
  • Delmar M. Lourenco Jr.,Flavia L.Coutinho, Rodrigo A. Toledo,Tatiana Denck Goncalves, Fabio L. M.Montenegro, Sergio P. A. Toledo. Clinics 2012;67:99-108

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329618/pdf/cln-67-s1-99.pdf

  • Surgical treatment of pancreatic endocrine tumors in multiple endocrine neoplasia type 1
  • Marcel Cerqueira Cesar Machado.Clinics 2012;67:145-148

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328825/pdf/cln-67-s1-145.pdf

  • Total parathyroidectomy in a large cohort of cases with hyperparathyroidism associated with multiple endocrine neoplasia type 1: experience from a single academic center
  • Fabio Luiz de Menezes Montenegro, Delmar Muniz Lourenço, Jr, [...], and Sergio Pereira Almeida Toledo.Clinics 2012;67:131-139

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328834/pdf/cln-67-s1-131.pdf

  • Current Concepts on Gastric Carcinoid Tumors
  • George C. Nikou and Theodoros P. Angelopoulos. Gastroenterol Res Pract. 2012;2012:287825. doi: 10.1155/2012/287825

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534241/pdf/GRP2012-287825.pdf

  • MENX and MEN4
  • Natalia S. Pellegata.Clinics 2012;67:13-18

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328816/pdf/cln-67-s1-13.pdf

  • Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
  • John K. Ramage et al. Gut 2012;61:6-32 doi:10.1136/gutjnl-2011-300831

    http://gut.bmj.com/content/61/1/6.full.pdf+html

  • Pituitary tumors in patients with MEN1 syndrome
  • Luis V. Syro, et al. Clinics 2012;67: 43-48

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328811/pdf/cln-67-s1-43.pdf

  • Surgical approach in patients with hyperparathyroidism in multiple endocrine neoplasia type 1: total versus partial parathyroidectomy
  • Francesco Tonelli, Francesco Giudici, [...], and Maria Luisa Brandi. Clinics 2012;67:155-160

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328832/pdf/cln-67-s1-155.pdf

    MEN 2

  • Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update
  • Samuel A. Wells, Jr, Furio Pacini, Bruce G. Robinson, and Massimo Santoro. J Clin Endocrinol Metab 2103; 98: 3149–3164

    http://jcem.endojournals.org/content/98/8/3149.full.pdf+html

  • Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
  • Maria Luisa Brandi et al J Clin Endocrinol Metab 2001; 86(12):5658–5671

    http://jcem.endojournals.org/content/86/12/5658.full.pdf+html

  • Modification of multiple endocrine neoplasia 2A phenotype by cell membrane proximity of RET mutations in exon 10
  • Andreas Machens, Steffen Hauptmann and Henning Dralle. Endocrine-Related Cancer 2009; 17: 171–177

    http://erc.endocrinology-journals.org/content/16/1/171.full.pdf+html

  • Codon-Specific Development of Pheochromocytoma in Multiple Endocrine Neoplasia Type 2
  • Andreas Machens, Michael Brauckhoff, Hans-Jurgen Holzhausen, Phuong Nguyen Thanh, Hendrik Lehnert, and Henning Dralle. The Journal of Clinical Endocrinology & Metabolism 90(7):3999–4003

    http://jcem.endojournals.org/content/90/7/3999.full.pdf+html

  • Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
  • Samuel A. Wells Jr, et al. Journal of Clinical Oncology 2010; 28: 767-72

    http://jco.ascopubs.org/content/28/5/767.full.pdf+html

  • Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype
  • K Frank-Raue, et al. European Journal of Endocrinology 2006;155: 229–236

    http://eje-online.org/content/155/2/229.full.pdf+html

  • Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms
  • Lucieli Ceolin, Débora R. Siqueira, Mírian Romitti, Carla V. Ferreira and Ana Luiza Maia. Int. J. Mol. Sci. 2012.13:221-239

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269683/pdf/ijms-13-00221.pdf

  • Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers the role of Ct serum level
  • Barbara Jarzab, Sylwia Szpak-Ulczok, Jan Wloch, Agnieszka Czarniecka, Jolanta Krajewska. Thyroid Research2013,6 (Suppl 1):S9

    http://www.thyroidresearchjournal.com/content/pdf/1756-6614-6-S1-S9.pdf

  • Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association. The American Thyroid Association Guidelines Task Force
  • Richard T. Kloos et al. Thyroid 2009;19 (6): 565-612

    http://thyroidguidelines.net/sites/thyroidguidelines.net/files/file/ATA_MTC_Guidelines_2009.pdf

  • Early Malignant Progression of Hereditary Medullary Thyroid Cancer
  • Andreas Machens et al. N Engl J Med 2003;349:1517-25

    http://www.nejm.org/doi/pdf/10.1056/NEJMoa012915

  • Modification of multiple endocrine neoplasia 2A phenotype by cell membrane proximity of RET mutations in exon 10
  • Andreas Machens, Steffen Hauptmann and Henning Dralle. Endocrine-Related Cancer 2009;16:171–177

    http://erc.endocrinology-journals.org/content/16/1/171.full.pdf+html

  • RET oncogene in MEN2, MEN2B, MTC, and other forms of thyroid cancer:molecular genetics and therapeutic advances
  • Maya B. Lodish, and Constantine A. Stratakis. Expert Rev Anticancer Ther 2008 April ; 8(4): 625–632

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670186/pdf/nihms101681.pdf

  • Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation
  • Ioana N Milos et al. Endocrine-Related Cancer 2008;15:1035–1041

    http://erc.endocrinology-journals.org/content/15/4/1035.full.pdf+html

  • Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management
  • Friedhelm Raue, Karin Frank-Raue. Hormones 2009, 8(1):23-28

    http://www.hormones.gr/pdf/MEN2.Genotype-phenotype%20relationship.pdf

  • Prognostic Factors of Disease-Free Survival after Thyroidectomy in 170 Young Patients with a RET Germline Mutation: A Multicenter Study of the Groupe Français d’Etude des Tumeurs Endocrines
  • V Rohmer et al. J Clin Endocrinol Metab 2011;96: E509–E518

    http://jcem.endojournals.org/content/96/3/E509.full.pdf+html

  • Kinase inhibitors for advanced medullary thyroid carcinoma
  • Martin Schlumberger et al. Clinics 2012;67:125-129

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328820/pdf/cln-67-s1-125.pdf

  • Hereditary Medullary Thyroid Cancer: Age-Appropriate Thyroidectomy Improves Disease-Free Survival
  • Kevin Shepet, BS et al. Ann Surg Oncol 2013 May ; 20(5): 1451–1455

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586982/pdf/nihms-417284.pdf

  • Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia Type 2ª
  • Michael A. Skinner et al. N Engl J Med 2005;353:1105-13

    http://www.nejm.org/doi/pdf/10.1056/NEJMoa043999

  • The Timing of Total Thyroidectomy in RET Gene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center
  • Rossella Elisei, et al. J Clin Endocrinol Metab 2012; 97: 426–435

    http://jcem.endojournals.org/content/97/2/426.full.pdf+html

    Feocromocitoma/Paraganglioma

  • TMEM127Screening in a Large Cohort of Patients with Pheochromocytoma and/or Paraganglioma
  • Nassera Abermil et al. J Clin Endocrinol Metab 2102;97:E805–E809

    http://jcem.endojournals.org/content/97/5/E805.full.pdf+htmll

  • Clinical and molecular genetics of patients with the Carney–Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB SDHC and SDHD
  • Barbara Pasini et al. European Journal of Human Genetics 2008; 16, 79-88

    http://www.nature.com/ejhg/journal/v16/n1/pdf/5201904a.pdf

  • Clinical aspects of SDHx-related pheochromocytoma and paraganglioma
  • Henri J L M Timmers, Anne-Paule Gimenez-Roqueplo, Massimo Mannelli and Karel Pacak. Endocrine-Related Cancer 2009;16: 391–400

    http://erc.endocrinology-journals.org/content/16/2/391.full.pdf+html

  • Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
  • Jenny Welander, Peter Soderkvist and Oliver Gimm Endocrine-Related Cancer; 2011: 18 R253–R276

    http://erc.endocrinology-journals.org/content/18/6/R253.full.pdf+html

  • Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma
  • Graeme Eisenhofer et al. Endocrine-Related Cancer; 2011:18: 97-111

    http://erc.endocrinology-journals.org/content/18/1/97.full.pdf+html

  • Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review
  • Rufini V., Treglia G., Castaldi P., Perotti G., Giordano A

    http://www.minervamedica.it/en/journals/nuclear-med-molecular-imaging/article.php?cod=R39Y2013N02A0122

  • Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators
  • Montserrat Ayala-Ramirez et al J Clin Endocrinol Metab 2011; 96:717-725

    http://jcem.endojournals.org/content/96/3/717.full.pdf+html

  • Carney Triad: A Syndrome Featuring Paraganglionic, Adrenocortical, and Possibly Other Endocrine Tumors
  • J. Aidan Carney. J Clin Endocrinol Metab 2009; 94:3656-3662

    http://jcem.endojournals.org/content/94/10/3656.full.pdf+html

  • Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas
  • Shankavaram U et al Neoplasia. 2013 Apr;15(4):435-47

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612915/pdf/neo1504_0435.pdfl

  • Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
  • Jenny Welander, Jenny Welander, Peter Söderkvist and Oliver Gimm. Endocrine-Related Cancer 2011; 18: R253–R276

    http://erc.endocrinology-journals.org/content/18/6/R253.full.pdf+html

  • Age at Diagnosis of Pheochromocytoma Differs According to Catecholamine Phenotype and Tumor Location
  • Graeme Eisenhofer et al. J Clin Endocrinol Metab 2011; 96: 375–384

    http://jcem.endojournals.org/content/96/2/375.full.pdf+html

  • Current and future therapeutic approaches for metastatic pheochromocytoma and paraganglioma: focus on SDHB tumors
  • Joey Matro, Alessio Giubellino, Karel Pacak. Horm Metab Res 2013 ; 45: 147–153

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577956/pdf/nihms417549.pdf

    © 2018 RegMEN | Desarrollado por IRICOM SL | Aviso Legal | Contacto